Novo Nordisk gets 2.0 mg Ozempic dose approved in US

The US Food and Drug Administration (FDA) has approved Ozempic in a 2.0 mg dose for the treatment of adults with type 2 diabetes.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app